Shattuck Labs (STTK) Change in Accured Expenses (2019 - 2026)
Shattuck Labs (STTK) reported Change in Accured Expenses of -$2.0 million for Q1 2026, down 173.04% year-over-year from $2.7 million in Q1 2025, and down 321.66% quarter-over-quarter from $882000.0 in Q4 2025.
Shattuck Labs (STTK) Change in Accured Expenses (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 8 years of Change in Accured Expenses data on file, last reported at -$2.0 million in Q1 2026.
- Change in Accured Expenses for Q1 2026 came in at -$2.0 million, down 173.04% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.7 million (down 25.87% YoY), and the FY2025 annual result was -$1.4 million, up 57.19% from the prior year.
- Change in Accured Expenses declined to -$2.0 million in Q1 2026 per STTK's latest filing, from $882000.0 in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $4.1 million in Q2 2022 and troughed at -$7.4 million in Q1 2023.
- A 5-year average of -$710764.7 and a median of -$687000.0 in 2025 frame the typical range for Change in Accured Expenses.
- The sharpest annual moves came in 2023 and 2024: Change in Accured Expenses tumbled 1123.96% in 2023, then soared 923.12% in 2024.
- A 5-year view of Change in Accured Expenses shows it stood at $1.9 million in 2022, then tumbled by 206.91% to -$2.0 million in 2023, then plunged by 45.81% to -$3.0 million in 2024, then jumped by 129.64% to $882000.0 in 2025, then tumbled by 321.66% to -$2.0 million in 2026.
- Business Quant data shows STTK's Change in Accured Expenses at -$2.0 million in Q1 2026, $882000.0 in Q4 2025, and -$687000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 931,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 70.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Shattuck Labs | 190.32 Mn | 190.32 Mn | - | -1.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.96 Mn |
| Mar 31, 2026 | -1.96 Mn |
| Dec 31, 2025 | 882,000.00 |
| Dec 31, 2025 | 882,000.00 |
| Sep 30, 2025 | -687,000.00 |
| Sep 30, 2025 | -687,000.00 |
| Jun 30, 2025 | -921,000.00 |
| Jun 30, 2025 | -921,000.00 |
| Mar 31, 2025 | -716,000.00 |
| Mar 31, 2025 | -716,000.00 |
| Dec 31, 2024 | -2.98 Mn |
| Dec 31, 2024 | -2.98 Mn |
| Sep 30, 2024 | -76,000.00 |
| Sep 30, 2024 | -76,000.00 |
| Jun 30, 2024 | 1.64 Mn |
| Jun 30, 2024 | 1.64 Mn |
| Mar 31, 2024 | -1.95 Mn |
| Mar 31, 2024 | -1.95 Mn |
| Dec 31, 2023 | -2.04 Mn |
| Dec 31, 2023 | -2.04 Mn |